Price$31.20-0.09 (-0.27%)
01:30 PM07:45 PM
News · 26 weeks39+300%
2026-04-192026-10-11
Mix990d
- SEC Filings5(56%)
- Earnings2(22%)
- Analyst1(11%)
- Other1(11%)
Latest news
25 items- SECSEC Form DEFA14A filed by Option Care Health Inc.DEFA14A - Option Care Health, Inc. (0001014739) (Filer)
- SECSEC Form DEFA14A filed by Option Care Health Inc.DEFA14A - Option Care Health, Inc. (0001014739) (Filer)
- SECSEC Form 8-K filed by Option Care Health Inc.8-K - Option Care Health, Inc. (0001014739) (Filer)
- PRCD&R and McKesson Corporation Sign Agreement to Acquire Option Care HealthCD&R, McKesson Corporation (NYSE:MCK) ("McKesson"), and Option Care Health, Inc. (NASDAQ:OPCH) ("Option Care Health") announced today that they have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health, an independent provider of home and alternate site infusion services, for $32.05 per share, reflecting a total enterprise value of approximately $5.8 billion. At the closing of the transaction, CD&R will hold a majority ownership interest, and McKesson will hold a minority ownership interest. Option Care Health will remain a separate company led by its own management team. "We are pleased to have entered into this agreement, which provides imme
- PROption Care Health to Participate in Upcoming Investor ConferencesBANNOCKBURN, Ill., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. ("Option Care Health") (NASDAQ:OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced that John Rademacher, CEO and Meenal Sethna, CFO, will participate in the following up coming investor conferences: Morgan Stanley 24th Annual Global Healthcare Conference, being held in New York City, on Tuesday, September 15, 2026 at 10:45am ET/9:45am CT.Deutsche Bank 2026 Healthcare Summit, being held in New York City, Wednesday, September 16, 2026. Webcast links and related presentation materials, if applicable, will be available online at https://investors.optioncarehealt
- ANALYSTOption Care Health downgraded by Deutsche Bank with a new price targetDeutsche Bank downgraded Option Care Health from Buy to Hold and set a new price target of $24.00
- SECSEC Form 10-Q filed by Option Care Health Inc.10-Q - Option Care Health, Inc. (0001014739) (Filer)
- PROption Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026BANNOCKBURN, Ill., July 29, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights (year-over-year comparisons unless otherwise noted) Net revenue of $1,442 million, up 1.9%GAAP net income of $53.9 million, up 6.7%GAAP diluted earnings per share of $0.35, up 12.9%Adjusted EBITDA of $117.5 million, up 3.0%Adjusted diluted earnings per share of $0.45, up 9.8%Cash provided by Q2 operating activities of $184 millionRepurchased $150 millio
- SECOption Care Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Option Care Health, Inc. (0001014739) (Filer)
- ANALYSTOption Care Health downgraded by Stephens with a new price targetStephens downgraded Option Care Health from Overweight to Equal-Weight and set a new price target of $24.00
- PROption Care Health to Announce Second Quarter 2026 Financial Results and Host Conference CallBANNOCKBURN, Ill., July 09, 2026 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2026 on Wednesday, July 29, 2026 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsParticipants can pre-register for the conference call at the following link: https://register-conf.media-server.com/register/BI808c970d451b4e5ba580364e7e07d20a. The call can also be accessed via a liv
- INSIDEREVP Sp Sales & Solutions Bhatia Prateek was granted 39,795 shares (SEC Form 4)4 - Option Care Health, Inc. (0001014739) (Issuer)
- INSIDERSEC Form 3 filed by new insider Bhatia Prateek3 - Option Care Health, Inc. (0001014739) (Issuer)
- ANALYSTGoldman initiated coverage on Option Care Health with a new price targetGoldman initiated coverage of Option Care Health with a rating of Neutral and set a new price target of $22.00
- PROption Care Health Appoints Robert Okunski as Vice President, Investor RelationsBANNOCKBURN, Ill., June 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced the appointment of Robert Okunski as Vice President, Investor Relations effective May 26, 2026. In this role, Okunski will lead the Company's investor relations strategy and serve as the primary liaison between Option Care Health and the investment community. He will be responsible for communicating the Company's business strategy, financial performance, capital allocation priorities and long-term growth opportunities to investors, analysts and other key stakeholders. "Bob brings more than two decade
- PROption Care Health Awarded TIME's World's Most Impactful Companies 2026 RankingBANNOCKBURN, Ill., June 01, 2026 (GLOBE NEWSWIRE) -- Option Care Health is proud to announce it has been ranked No. 15 on the World's Most Impactful Companies 2026 list, a global recognition of organizations delivering measurable positive impact across society, the environment, and the economy. This recognition is presented by TIME and Statista, global leaders in data analysis and industry benchmarking, and it can now be viewed on time.com. Being named to the World's Most Impactful Companies 2026 list signifies that Option Care Health stands among a select group of organizations driving meaningful change through their core business activities. Unlike perception-based assessments or self-r
- INSIDERDirector Bierbower Elizabeth D was granted 8,997 shares, increasing direct ownership by 38% to 32,871 units (SEC Form 4)4 - Option Care Health, Inc. (0001014739) (Issuer)
- INSIDERDirector Deckmann Natasha was granted 9,841 shares, increasing direct ownership by 44% to 32,002 units (SEC Form 4)4 - Option Care Health, Inc. (0001014739) (Issuer)
- INSIDERDirector Kraemer Harry M Jansen Jr was granted 21,076 shares, increasing direct ownership by 5% to 471,076 units (SEC Form 4)4 - Option Care Health, Inc. (0001014739) (Issuer)
- INSIDERDirector Pate R Carter was granted 8,997 shares, increasing direct ownership by 77% to 20,620 units (SEC Form 4)4 - Option Care Health, Inc. (0001014739) (Issuer)
- INSIDERDirector Sullivan Timothy P was granted 13,833 shares, increasing direct ownership by 19% to 87,216 units (SEC Form 4)4 - Option Care Health, Inc. (0001014739) (Issuer)
- INSIDERDirector Bodem Barbara W. was granted 8,997 shares, increasing direct ownership by 74% to 21,087 units (SEC Form 4)4 - Option Care Health, Inc. (0001014739) (Issuer)
- INSIDERDirector Wright Norman L. was granted 8,997 shares, increasing direct ownership by 58% to 24,498 units (SEC Form 4)4 - Option Care Health, Inc. (0001014739) (Issuer)
- INSIDERDirector Brandt Eric was granted 11,640 shares, increasing direct ownership by 112% to 21,999 units (SEC Form 4)4 - Option Care Health, Inc. (0001014739) (Issuer)
- SECOption Care Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Option Care Health, Inc. (0001014739) (Filer)
OPCH FAQ
6 questionsWhat does Option Care Health Inc. do?
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral...Where does OPCH stock trade?
Option Care Health Inc. (OPCH) is listed on NASDAQ.What sector and industry is OPCH in?
Option Care Health Inc. operates in the Health Care sector, Medical/Nursing Services industry.What are analysts saying about OPCH?
Option Care Health Inc. has had 8 recent analyst actions on file. The most recent action was from Deutsche Bank: Hold with a $2400.00 price target on 2026-07-30. Recent price targets range from $2200.00 to $4000.00.What companies are similar to OPCH?
Notable peers in the same industry include BTSG (BrightSpring Health Services Inc.), CHE (Chemed Corp), HIMS (Hims & Hers Health Inc.), LFST (LifeStance Health Group Inc.), AMED (Amedisys Inc). Compare OPCH side-by-side with any of them on Quantisnow.How can I track OPCH on Quantisnow?
Quantisnow aggregates Option Care Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow OPCH to receive live email and push alerts on every new disclosure.